8 ud af 8 tidsskrifter valgt, ingen søgeord valgt, emner højest 7 dage gamle, sorteret efter nyeste først.
25 emner vises.
1
New and Improved Option for Detecting Neurologic Pathogens?
Medscape Infectious Diseases, 18.04.2024
Tilføjet 18.04.2024
A new test appears to be better than current options for diagnosing pathogens that cause meningitis, encephalitis, and other neurologic infections. Medscape Medical News
Læs mere
2
Surveillance of COVID-19 in long-term care facilities in the EU/EEA 2021-2023
ECDC
ECDC COVID-19 updates, 17.04.2024
Tilføjet 17.04.2024
This report collects all COVID-19 long-term care facilities (LTCF) data reported to ECDC from 2021 and concludes the EU/EEA LTCF COVID-19 specific surveillance data collection from 2021-2023.
Læs mere
3
4 Years In, a Sobering Look at Long COVID Progress
Medscape Infectious Diseases, 16.04.2024
Tilføjet 16.04.2024
Where long COVID treatment and research is right now — and where it\'s going. Medscape Medical News
Læs mere
4
FDA Approves AI Diagnostic Tool for Early Sepsis Detection
Medscape Infectious Diseases, 15.04.2024
Tilføjet 15.04.2024
The first-ever AI diagnostic tool for sepsis was granted marketing authorization through the FDA\'s De Novo pathway. Medscape Medical News
Læs mere
5
COVID Vaccinations Less Prevalent in Marginalized Patients
Medscape Infectious Diseases, 15.04.2024
Tilføjet 15.04.2024
Primary care doctors who serve marginalized communities had the highest rate of patients unvaccinated against COVID-19 in a recent study. Medscape Medical News
Læs mere
6
Weekly respiratory virus update, week 14, April 2024
ECDC
ECDC COVID-19 updates, 15.04.2024
Tilføjet 15.04.2024
Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels.
Læs mere
7
Measles Outbreak: Vital Updates for Your Practice
Medscape Infectious Diseases, 13.04.2024
Tilføjet 13.04.2024
Measles resurgence threatens global health, with rising cases and travel-related risks. Experts discuss the outbreak\'s impact on healthcare. Medscape Infectious Diseases
Læs mere
8
What's Behind Long-Term Antibiotic Prescribing for Acne?
Medscape Infectious Diseases, 12.04.2024
Tilføjet 12.04.2024
\'This study explored why dermatologists still prescribe a good number of long-term antibiotics for people with acne,\' the study\'s senior author Howa Yeung, MD, MSc, said in an interview. MDedge News
Læs mere
9
Are You Ready for AI to Be a Better Doctor Than You?
Medscape Infectious Diseases, 12.04.2024
Tilføjet 12.04.2024
Study after study show AI outperforming MDs in all areas. How should all-too-human physicians — who have trained for years to be good at what they do — feel about this? Medscape Medical News
Læs mere
10
Vaccine 'Will Not Curb' Dengue Epidemic, Says PAHO
Medscape Infectious Diseases, 12.04.2024
Tilføjet 12.04.2024
The vaccine should be used alongside measures such as vector control, prevention, and education, according to the organization. Medscape Medical News
Læs mere
11
Communicable disease threats report, 7 - 13 April 2024, week 15
ECDC
ECDC COVID-19 updates, 12.04.2024
Tilføjet 12.04.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7 - 13 April 2024 and includes updates on measles, avian influenza, COVID-19, Mpox, seasonal influenza, RSV, cholera and shigellosis.
Læs mere
12
ECDC: On Air - Episode 49 - Nick Bundle - Why Monitoring Respiratory Viruses Matters
ECDC
ECDC COVID-19 updates, 12.04.2024
Tilføjet 12.04.2024
In this episode we take a closer look at the data collection for respiratory viruses and why we should take this more seriously than just a cough or a sneeze.
Læs mere
13
Communicable disease threats report, 7 - 13 April 2024, week 15
ECDC
ECDC Communicable Disease Threats Report, 12.04.2024
Tilføjet 12.04.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7 - 13 April 2024 and includes updates on measles, avian influenza, COVID-19, Mpox, seasonal influenza, RSV, cholera and shigellosis.
Læs mere
14
Vaccine til beskyttelse mod klamydia-øjeninfektioner viser lovende resultater
Statens Serum Institut, 12.04.2024
Tilføjet 12.04.2024
Forskere fra Statens Serum Institut er kommet et skidt nærmere en vaccine til beskyttelse mod øjensygdommen trachoma, der er forårsaget af klamydia-bakterien, og som er den hyppigste infektiøse årsag til blindhed på verdensplan
Læs mere
15
High Infection Risk in RA-Associated ILD
Medscape Infectious Diseases, 12.04.2024
Tilføjet 12.04.2024
A prospective study found that 96% of patients with RA-ILD had at least one serious infection, which proved fatal in 65% of cases. Medscape Medical News
Læs mere
16
Integrating Telemedicine for HCV With OUD Treatment Works
Medscape Infectious Diseases, 12.04.2024
Tilføjet 12.04.2024
Integrating HCV treatment into opioid treatment programs improves access to HCV treatment, leading to high cure rates, new research shows. Medscape Medical News
Læs mere
17
Epidemiology, resistance genomics and susceptibility of Acinetobacter species: results from the 2020 Spanish nationwide surveillance study
Cristina Lasarte-Monterrubio, Paula Guijarro-Sánchez, Isaac Alonso-Garcia, Michelle Outeda, Romina Maceiras, Lucia González-Pinto, Marta Martínez-Guitián, Carlos Fernández-Lozano, Juan Carlos Vázquez-Ucha, German Bou, Jorge Arca-Suárez and Alejandro Beceiro
Eurosurveillance latest updates, 12.04.2024
Tilføjet 12.04.2024
BackgroundAs increasing antibiotic resistance in Acinetobacter baumannii poses a global healthcare challenge, understanding its evolution is crucial for effective control strategies. AimWe aimed to evaluate the epidemiology, antimicrobial susceptibility and main resistance mechanisms of Acinetobacter spp. in Spain in 2020, and to explore temporal trends of A. baumannii. MethodsWe collected 199 single-patient Acinetobacter spp. clinical isolates in 2020 from 18 Spanish tertiary hospitals. Minimum inhibitory concentrations (MICs) for nine antimicrobials were determined. Short-read sequencing was performed for all isolates, and targeted long-read sequencing for A. baumannii. Resistance mechanisms, phylogenetics and clonality were assessed. Findings on resistance rates and infection types were compared with data from 2000 and 2010. ResultsCefiderocol and colistin exhibited the highest activity against A. baumannii, although colistin susceptibility has significantly declined over 2 decades. A. non-baumannii strains were highly susceptible to most tested antibiotics. Of the A. baumannii isolates, 47.5% (56/118) were multidrug-resistant (MDR). Phylogeny and clonal relationship analysis of A. baumannii revealed five prevalent international clones, notably IC2 (ST2, n = 52; ST745, n = 4) and IC1 (ST1, n = 14), and some episodes of clonal dissemination. Genes blaOXA-23, blaOXA-58 and blaOXA-24/40 were identified in 49 (41.5%), eight (6.8%) and one (0.8%) A. baumannii isolates, respectively. ISAba1 was found upstream of the gene (a blaOXA-51-like) in 10 isolates. ConclusionsThe emergence of OXA-23-producing ST1 and ST2, the predominant MDR lineages, shows a pivotal shift in carbapenem-resistant A. baumannii (CRAB) epidemiology in Spain. Coupled with increased colistin resistance, these changes underscore notable alterations in regional antimicrobial resistance dynamics.
Læs mere
18
Emergence of OXA-48-like producing Citrobacter species, Germany, 2011 to 2022
Julian Sommer, Hannah Reiter, Janko Sattler, Elisabetta Cacace, Jessica Eisfeld, Sören Gatermann, Axel Hamprecht and Stephan Göttig
Eurosurveillance latest updates, 12.04.2024
Tilføjet 12.04.2024
BackgroundCarbapenemase-producing Enterobacterales are a public health threat worldwide and OXA-48 is the most prevalent carbapenemase in Germany and western Europe. However, the molecular epidemiology of OXA-48 in species other than Escherichia coli and Klebsiella pneumoniae remains poorly understood. AimTo analyse the molecular epidemiology of OXA-48 and OXA-48-like carbapenemases in Citrobacter species (spp.) in Germany between 2011 and 2022. MethodsData of 26,822 Enterobacterales isolates sent to the National Reference Centre (NRC) for Gram-negative bacteria were evaluated. Ninety-one Citrobacter isolates from 40 German hospitals harbouring blaOXA-48/OXA-48‑like were analysed by whole genome sequencing and conjugation experiments. ResultsThe frequency of OXA-48 in Citrobacter freundii (CF) has increased steadily since 2011 and is now the most prevalent carbapenemase in this species in Germany. Among 91 in-depth analysed Citrobacter spp. isolates, CF (n = 73) and C. koseri (n = 8) were the most common species and OXA-48 was the most common variant (n = 77), followed by OXA-162 (n = 11) and OXA‑181 (n = 3). Forty percent of the isolates belonged to only two sequence types (ST19 and ST22), while most other STs were singletons. The plasmids harbouring blaOXA‑48 and blaOXA-162 belonged to the plasmid types IncL (n = 85) or IncF (n = 3), and plasmids harbouring blaOXA‑181 to IncX3 (n = 3). Three IncL plasmid clusters (57/85 IncL plasmids) were identified, which were highly transferable in contrast to sporadic plasmids. ConclusionIn CF in Germany, OXA-48 is the predominant carbapenemase. Dissemination is likely due to distinct highly transmissible plasmids harbouring blaOXA‑48 or blaOXA-48-like and the spread of the high-risk clonal lineages ST19 and ST22.
Læs mere
19
Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024
Sarah K Nørgaard, Jens Nielsen, Anne Christine Nordholm, Lukas Richter, Alena Chalupka, Natalia Bustos Sierra, Toon Braeye, Maria Athanasiadou, Theodore Lytras, Gleb Denissov, Oskari Luomala, Anne Fouillet, Isabelle Pontais, Matthias an der Heiden, Benedikt Zacher, Alina Weigel, Ivo Foppa, Kassiani Gkolfinopoulou, Ioannis Panagoulias, Anna Paldy, Tibor Malnasi, Lisa Domegan, Eva Kelly, Naama Rotem, Oksana Rakhlin, Francesca K de'Donato, Chiara Di Blasi, Patrick Hoffmann, Telma Velez, Kathleen England, Neville Calleja, Liselotte van Asten, Femke Jongenotter, Ana Paula Rodrigues, Susana Silva, Petra Klepac, Diana Gomez-Barroso, Inmaculada Leon Gomez, Ilias Galanis, Ahmed Farah, Rolf Weitkunat, Katarina Fehst, Nick Andrews, Tom Clare, Declan T Bradley, Mark G O'Doherty, Naoma William, Mark Hamilton, Bolette Søborg, Tyra G Krause, Nick Bundle and Lasse S Vestergaard
Eurosurveillance latest updates, 12.04.2024
Tilføjet 12.04.2024
Since the end of November 2023, the European Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023–6 2024, preliminary results show a substantially increased rate of 95.3 (95% CI: 91.7–98.9) excess all-cause deaths per 100,000 person-years for all ages. This excess mortality is seen in adults aged 45 years and older, and coincides with widespread presence of COVID-19, influenza and respiratory syncytial virus (RSV) observed in many European countries during the 2023/24 winter season.
Læs mere
20
Notes from the Field: Neonatal Salmonellosis Associated with Backyard Poultry - Oregon, November 2023
Morbidity and Mortality Weekly Report (MMWR), 12.04.2024
Tilføjet 12.04.2024
This report describes a case of salmonellosis associated with backyard poultry in a newborn.
Læs mere
21
Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults After Receipt of COVID-19 Vaccine - Oregon, June 2021-December 2022
Morbidity and Mortality Weekly Report (MMWR), 12.04.2024
Tilføjet 12.04.2024
This report describes a review of Oregon death certificate data to assess whether young people in Oregon might be dying after receiving a COVID-19 vaccine.
Læs mere
22
Infections Associated with Medtronic Duet External Ventricular Drains - Rhode Island Hospital, Providence, Rhode Island, January 2023-January 2024
Morbidity and Mortality Weekly Report (MMWR), 12.04.2024
Tilføjet 12.04.2024
This report describes an investigation of external ventricular drain-associated infections at a Rhode Island hospital.
Læs mere
23
COVID-19 Vaccination Coverage - World Health Organization African Region, 2021-2023
Morbidity and Mortality Weekly Report (MMWR), 12.04.2024
Tilføjet 12.04.2024
This report describes COVID-19 vaccination coverage in the World Health Organization African Region during 2021-2023.
Læs mere
24
Measles - United States, January 1, 2020-March 28, 2024
Morbidity and Mortality Weekly Report (MMWR), 12.04.2024
Tilføjet 12.04.2024
This report describes measles cases in the United States during 2020-2024
Læs mere
25
State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Accessing Treatments - United States, 2018-2022
Morbidity and Mortality Weekly Report (MMWR), 12.04.2024
Tilføjet 12.04.2024
This report describes state Medicaid coverage of tobacco cessation treatments.
Læs mere